DMEM, high glucose, GlutaMAX Supplement, pyruvate, 500 mL and 1 more item

Life Technologies Corporation has been awarded contract A207_PO-0468642 by the University of Virginia, an institution within the Commonwealth of Virginia. The contract was executed on August 13, 2026, with a cumulative value of $2,543.30. This modest contract value indicates a purchase order arrangement for specialized products or services within Life Technologies Corporation's commercial offerings, which typically encompass life science research equipment, reagents, and related consumables.

While the specific products and services rendered under this purchase order are not detailed in the available contract documentation, Life Technologies Corporation's portfolio suggests the deliverables likely consist of laboratory reagents, molecular biology consumables, or analytical instrumentation components commonly procured by academic research institutions. The University of Virginia, serving as the contracting organization and presumed place of performance, would utilize these materials to support ongoing research and educational initiatives. The contract term and annual value breakdown are not specified in the award notice; however, the cumulative value designation indicates this represents a single transaction or a closed purchase order with limited scope.